From research to therapy – what you need to know early to develop cell and gene therapies

On 30 September, a half-day training will be held at Medicon Village for researchers working in cell and gene therapy. This training is organised within the ATMP Path2Patient project.
 
The speakers focus on how early decisions in research can influence what is possible later in the development of new therapies. Topics include funding pathways, how to protect research results, and how early scientific choices relate to future development, manufacturing, and clinical feasibility.
 
The training is open to researchers at all levels and does not require a defined development project. It also provides an overview of available support and resources within the ATMP field in the region.